CUPERTINO, CA and HYDERABAD, INDIA - (NewMediaWire) - June 13, 2019 - Aemetis, Inc. (NASDAQ: AMTX) announced today that its Universal Biofuels India subsidiary achieved record domestic biodiesel revenues in May as shipments commenced under the previously announced $23 million biodiesel supply contract to the three government-owned Oil Marketing Companies (OMC’s).
“The supply arrangement announced in March has now resulted in a rapid ramp-up of biodiesel deliveries to about $4 million for the month of May, which was the first month of shipments to OMC’s,” stated Eric McAfee, Chairman and CEO of Aemetis. “The India business continues to expand its market reach by winning new customers in trucking, mining and construction. We are also expanding the number of retail fueling stations in India that sell our clear, distilled, Universal Biofuels brand biodiesel.”
The Aemetis biodiesel plant in India recently completed the installation and commissioning of a pretreatment plant and related utilities upgrades to convert lower cost, waste feedstocks into high quality distilled biodiesel to supply the approximately 25 billion gallon diesel market in India.
Headquartered in Cupertino, California, Aemetis is an advanced renewable fuels and biochemicals company focused on the acquisition, development and commercialization of innovative technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into advanced biorefineries. Founded in 2006, Aemetis owns and operates a 60 million gallon per year ethanol production facility in California’s Central Valley, near Modesto. Aemetis also owns and operates a 50 million gallon per year renewable chemical and advanced fuel production facility on the East Coast of India producing high quality distilled biodiesel and refined glycerin for customers in India, the US and Europe. Aemetis is building a dairy digester, pipeline and gas conditioning system near its plant in California to produce below zero carbon content Renewable Natural Gas (RNG). Aemetis operates a research and development laboratory, and holds a portfolio of patents and related technology licenses for the production of renewable fuels and biochemicals. For additional information about Aemetis, please visit www.aemetis.com.
Safe Harbor Statement
This news release contains forward-looking statements, including statements regarding our assumptions, projections, expectations, targets, intentions or beliefs about future events or other statements that are not historical facts. Forward-looking statements in this news release include, without limitation, statements relating to the production or effectiveness of the India production facility, the achievement of market expansion for products produced at the India production facility, and the continuance of governmental mandates for biodiesel. Words or phrases such as “anticipates,” “may,” “will,” “should,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “showing signs,” “targets,” “will likely result,” “will continue” or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based on current assumptions and predictions and are subject to numerous risks and uncertainties. Actual results or events could differ materially from those set forth or implied by such forward-looking statements and related assumptions due to certain factors, including, without limitation, competition in the ethanol, biodiesel and other industries in which we operate, commodity market risks including those that may result from current weather conditions, financial market risks, customer adoption, counter-party risks, risks associated with changes to federal policy or regulation, and other risks detailed in our reports filed with the Securities and Exchange Commission (the “SEC”), including our Annual Report on Form 10-K for the year ended December 31, 2018, and in our subsequent filings with the SEC. We are not obligated, and do not intend, to update any of these forward-looking statements at any time unless an update is required by applicable securities laws.
External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 firstname.lastname@example.org Company Investor Relations/ Media Contact: Todd Waltz (408) 213-0940 email@example.com